Temasek Holdings (Private) LTD Orchard Therapeutics PLC Transaction History

Temasek Holdings (Private) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.44 - $5.38 $1.9 Million - $23.2 Million	-4,319,049 Closed	0 $0
Q2 2022 May 15, 2023	BUY	$0.42 - $0.78 $1.39 Million - $2.59 Million	3,319,049 Added 331.9%	4,319,049 $2.51 Million
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.78 $1.39 Million - $2.59 Million	3,319,049 Added 331.9%	4,319,049 $2.52 Million
Q1 2022 May 15, 2023	SELL	$0.7 - $1.51 $2.32 Million - $5.01 Million	-3,319,049 Reduced 76.85%	1,000,000 $710,000
Q4 2018 Feb 14, 2019	BUY	$12.4 - $18.7 $12.4 Million - $18.7 Million	1,000,000 New	1,000,000 $15.7 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

Stay updated on Temasek Holdings (Private) LTD with notifications on news.